Stephen R Bertenshaw

This inventor holds 41 USPTO granted patents, plus 2 CIPO patents, primarily in Anti-Inflammatory Agents. Top assignees: G.d. Searle & Company, Pharmacia Corporation, Bristol-Myers Squibb Compnay. Active years: 1995-2013.

USPTO Granted Patents = 41

% Patents Active = 78.0

CIPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 6.2

ph-index = 14

Forward Citations = 753(Granted Patents)

Location History:

Brentwood, MO (US) (1995 - 2006)
Cheshire, CT (US) (2000 - 2013)

Company Filing History:

27 out of 1,323

G.d. Searle & Company

patents

4 out of 220

Pharmacia Corporation

patents

3 out of 3,737

Bristol-Myers Squibb Compnay

Bristol-Meyers Squibb

patents

6. 1 out of 5

Pharmacia Corporation (of Pfizer, Inc.)

patents

7. 3 out of 834,453

Other

patents

Years Active: 1995-2013

Loading Chart...

Areas of Expertise:

Anti-Inflammatory

Benzopyran Derivatives

Pyrazolyl Compounds

Benzenesulfonamide

Prodrugs

Melatonergic Agents

Thiophenes

Furans

Heterocycles

COX-2 Inhibitors

Amino Derivatives

Inflammation Treatment

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE44048 - 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorder (2013-03-04),

2. 7420061 - Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors (2008-09-02),

3. 7138411 - Substituted benzopyran derivatives for the treatment of inflammation (2006-11-21),

4. 7109211 - Substituted benzopyran derivatives for the treatment of inflammation (2006-09-19),

5. 7030153 - 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents (2006-04-18),

6. 7012094 - Substituted furans and furanones for the treatment of inflammation (2006-03-14),

7. 6951949 - Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation (2005-10-04),

8. 6908931 - Tetrahydroisoquinoline derivatives as melatonin MT2 antagonists (2005-06-21),

9. 6815460 - Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors (2004-11-09),

10. 6806288 - Substituted benzopyran derivatives for the treatment (2004-10-19),

11. 6737431 - Benzoxazole derivatives as novel melatonergic agents (2004-05-18),

12. 6716991 - Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation (2004-04-06),

13. 6599934 - 3,4-diaryl thiopenes and analogs thereof having use as antiinflammatory agents (2003-07-29),

14. 6586603 - Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation (2003-07-01),

15. 6569894 - Arylalkylbenzofuran derivatives as melatonergic agents (2003-05-27),

Title: The Inventor Stephen R Bertenshaw: Pioneering Innovations in Brentwood

Introduction: Stephen R Bertenshaw is a distinguished inventor based in Brentwood, MO, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Stephen R Bertenshaw holds several patents in the areas of technology, healthcare, and consumer products, showcasing his versatility and ingenuity in inventing novel solutions.

Career Highlights: Throughout his illustrious career, Stephen R Bertenshaw has consistently pushed the boundaries of innovation, with his inventions revolutionizing industries and improving the lives of many.

Collaborations: Stephen R Bertenshaw has collaborated with leading companies, research institutions, and universities to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Stephen R Bertenshaw's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, leaving a lasting impact on the world of inventions.